Bibliographic citations
Aguilar, V., Ataucury, D. (2024). Impacto de la pandemia por COVID-19 en la mortalidad cardiovascular durante el periodo 2017-2021 en el Perú [Universidad Peruana Cayetano Heredia]. https://hdl.handle.net/20.500.12866/16542
Aguilar, V., Ataucury, D. Impacto de la pandemia por COVID-19 en la mortalidad cardiovascular durante el periodo 2017-2021 en el Perú []. PE: Universidad Peruana Cayetano Heredia; 2024. https://hdl.handle.net/20.500.12866/16542
@misc{renati/1060436,
title = "Impacto de la pandemia por COVID-19 en la mortalidad cardiovascular durante el periodo 2017-2021 en el Perú",
author = "Ataucury Arones, Dayanne Nicole",
publisher = "Universidad Peruana Cayetano Heredia",
year = "2024"
}
Introduction: The COVID-19 pandemic has had a considerable impact on morbimortality, mainly affecting people with cardiovascular comorbidities. This study seeks to determine the impact of the pandemic on cardiovascular mortality in Peru, information that is still unknown in this context. Objective: To evaluate the impact of the COVID-19 pandemic on cardiovascular mortality in Peru. Materials and methods: Descriptive, cross-sectional, case series study, based on death data from SINADEF (2017-2021). The periods before the pandemic (2017-2019) and during the pandemic (2020-2021) were compared. Cardiovascular mortality was defined as deaths due to acute coronary syndrome (ACS), heart failure (HF), ventricular arrhythmia (VA), cerebrovascular accident (CVA), cardiogenic shock (CS), pulmonary embolism (PE), deep vein thrombosis (DVT) and aortic disease (AD). Results: A total of 761,153 deaths were recorded, of which 16.18% (n=123,148) corresponded to cardiovascular causes. An increase in cardiovascular mortality was observed, from 12.62% in 2019 to 18.82% in 2020 and 18.09% in 2021, with a total excess of 5.70%. The causes most associated with COVID-19 infection were ACS [PR: 1.24 IC(1,22-1,26)], HF [PR: 1.58 IC(1,56-1,61)], VA [PR: 1.71 IC(1,58-1,85)], CS [PR: 2.03 IC(1,98-2,08)], and PE [PR: 1.97 IC(1,90-2,04)]. On the other hand, no important changes were observed in CVA, DVT, and AD. Conclusions: There was evidence of an increase in cardiovascular mortality during the pandemic in Peru.
This item is licensed under a Creative Commons License